This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Star Scientific's Rock Creek Pharmaceuticals, Inc. Launches Anatabloc® Face Cream

GLEN ALLEN, Va., Sept. 10, 2012 /PRNewswire/ -- Star Scientific, Inc. (NASDAQ: STSI) through its wholly owned subsidiary Rock Creek Pharmaceuticals, Inc. announced today that the Company's new Anatabloc® face cream is now available on the cosmetic portion of the Anatabloc® website ( and in select dermatology practices. 

(Photo: )

(Logo: )

Star Scientific and Rock Creek Pharmaceuticals have been developing this new face cream for more than two years. The product is a unique formulation of anatabine citrate and a botanically-based emollient. (Anatabine citrate is one of the active ingredients in the Company's successful Anatabloc® nutritional supplement.)  The Anatabloc® face cream has been demonstrated to considerably improve the appearance of the skin in a broad variety of volunteers and in a case series conducted by leading dermatologist Dr. Susan H. Weinkle of Bradenton, Florida, President of the American Society for Dermatologic Surgery and Assistant Clinical Professor of Dermatology at the University of South Florida.

Dr. Weinkle stated, "My dermatology colleagues and I are very excited about the new Anatabloc® face cream. In my opinion, it represents a genuine breakthrough in improving the appearance of the skin, especially in difficult cases. I selected patients who had significant needs and who had not responded to other cosmetic creams. It clearly worked where other creams had failed, and we have initiated further study to define where it may be of greatest benefit."

Dr. Marina Landau, a prominent medical and cosmetic dermatologist in Israel who is Immediate Past President of the Israeli Society for Dermatologic Surgery and a member of the board of directors of the International Society for Dermatologic Surgery, commented, "I had a patient who had significant redness after a surgical peel.  I was astounded by the improvement in the appearance of the skin after she used the Anatabloc® cream for just a short amount of time. It was a surprise and like nothing I have ever seen. The improvement in the appearance of the skin was prompt, significant, and very gratifying to the patient. I really look forward to working with this product."

Paul L. Perito, Rock Creek's Chairman and CEO, stated, "I have been following the development of our cosmetic cream formulation with considerable excitement. Our mission to use botanically based products to promote a healthy lifestyle has been enhanced by the addition of this line extension, Anatabloc® face cream."

Certain statements contained in this release constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements include, but are not limited to statements identified by words such as "believes," "expects," "anticipates," "estimates," "intends," "plans," "targets," "projects" and similar expressions. The statements in this release are based upon the current beliefs and expectations of our company's management and are subject to significant risks and uncertainties. Actual results may differ from those set forth in the forward-looking statements. Numerous factors could cause or contribute to such differences, including, but not limited to, results of clinical trials, the challenges inherent in new product development initiatives, including the continued development and market acceptance of our nutraceutical and low-TSNA tobacco products, our ability to license and protect our intellectual property, our ability to raise additional capital in the future that is necessary to maintain our business, changes in government policy and/or regulation, including with respect to our nutraceutical and low-TSNA tobacco products, as well as other risks discussed from time to time in our filings with the Securities and Exchange Commission, including, without limitation, our annual report on Form 10-K for the fiscal year ended December 31, 2011. We undertake no duty to update any forward-looking statement or any information contained in this press release or in other public disclosures at any time.

About Star Scientific Star Scientific, Inc. is a technology-oriented company with a mission to promote maintenance of a healthy metabolism, as well as to reduce the harm associated with the use of tobacco at every level. Over the last several years, through its wholly owned subsidiary, Rock Creek Pharmaceuticals, Star Scientific has been engaged in the manufacturing, sale, and marketing of two nutraceutical dietary supplements, and the development of other nutraceuticals and pharmaceuticals. The company also has continued to pursue the development, implementation, and licensing of the technology behind its proprietary StarCured® tobacco curing process, which substantially prevents the formation of carcinogenic toxins present in tobacco and tobacco smoke, primarily the tobacco-specific nitrosamines, or TSNAs and related low-TSNA dissolvable tobacco products. Rock Creek Pharmaceuticals has scientific and research offices in Gloucester, MA, and a regulatory office in Washington, DC. Star Scientific has a Corporate and Sales Office in Glen Allen, VA; Executive, Scientific & Regulatory Affairs offices in Bethesda, MD, and Washington, DC; and a manufacturing facility in Chase City, VA.

Contact: Talhia T. TuckVice President, Communications and Investor RelationsStar Scientific, Inc. (301) 654-8300

SOURCE Star Scientific, Inc.

Copyright 2011 PR Newswire. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free


Chart of I:DJI
DOW 17,050.75 +138.46 0.82%
S&P 500 1,995.83 +15.91 0.80%
NASDAQ 4,810.7880 +19.6360 0.41%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs